FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

S m Pond

Research Profile

Chemicals & Drugs

Procedures

Anatomy

Livers

Concepts & Ideas

Living Beings

Co-author Network

Publications

TOP 3
Gerhard A Siebert; S m Pond; Lesley J Bryan-Lluka
Further characterisation of the interaction of haloperidol metabolites with neurotransmitter transporters in rat neuronal cultures and in transfected COS-7 cells.
Darryl W Eyles; S m Pond; Cornelis J Van Der Schyf; G M Halliday
Mitochondrial ultrastructure and density in a primate model of persistent tardive dyskinesia.
SJ McCann; Michael E McManus; AG Johnson; George D Mellick; DAVID LE COUTEUR; S m Pond
The serotonin transporter gene and Parkinson's disease.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of S m Pond (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2000: Gerhard A Siebert; S m Pond; Lesley J Bryan-Lluka
Further characterisation of the interaction of haloperidol metabolites with neurotransmitter transporters in rat neuronal cultures and in transfected COS-7 cells.
Naunyn-Schmiedeberg's archives of pharmacology 2000;361(3):255-64.
2000: Darryl W Eyles; S m Pond; Cornelis J Van Der Schyf; G M Halliday
Mitochondrial ultrastructure and density in a primate model of persistent tardive dyskinesia.
Life sciences 2000;66(14):1345-50.
2000: SJ McCann; Michael E McManus; AG Johnson; George D Mellick; DAVID LE COUTEUR; S m Pond
The serotonin transporter gene and Parkinson's disease.
European neurology 2000;44(2):108-11.
1999: Lesley J Bryan-Lluka; Gerhard A Siebert; S m Pond
Potencies of haloperidol metabolites as inhibitors of the human noradrenaline, dopamine and serotonin transporters in transfected COS-7 cells.
Naunyn-Schmiedeberg's archives of pharmacology 1999;360(2):109-15.
1999: Linda Truong; S m Pond; HR Cartwright; DA McRitchie; Neal Castagnoli; Cornelis J Van Der Schyf
Clinical and neuropathological abnormalities in baboons treated with HPTP, the tetrahydropyridine analog of haloperidol.
Experimental neurology 1999;158(1):155-63.
1998: DA McRitchie; HR Cartwright; S m Pond; Cornelis J Van Der Schyf; Neal Castagnoli; D G van der Nest; Linda Truong
The midbrain dopaminergic cell groups in the baboon Papio ursinus.
Brain research bulletin 1998;47(6):611-23.
1998: Darryl W Eyles; John J McGrath; Terry Stedman; S m Pond
Chirality of reduced haloperidol in humans.
European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology 1998;8(2):127-9.
1998: Paul J Taylor; C E Jones; P T Martin; Stephen V Lynch; AG Johnson; S m Pond
Microscale high-performance liquid chromatography-electrospray tandem mass spectrometry assay for cyclosporin A in blood.
Journal of chromatography. B, Biomedical sciences and applications 1998;705(2):289-94.
1998: SJ McCann; DAVID LE COUTEUR; A C Green; Carol Brayne; AG Johnson; D Chan; Michael E McManus; S m Pond
The epidemiology of Parkinson's disease in an Australian population.
Neuroepidemiology 1998;17(6):310-7.
1997: SJ McCann; S m Pond; KM James; DAVID LE COUTEUR
The association between polymorphisms in the cytochrome P-450 2D6 gene and Parkinson's disease: a case-control study and meta-analysis.
Journal of the neurological sciences 1997;153(1):50-3.
1997: Paul Salm; Paul J Taylor; A Clark; Glenda A Balderson; A Grygotis; Ross L G Norris; Stephen V Lynch; L M Shaw; S m Pond
High-performance liquid chromatography-tandem mass spectrometry as a reference for analysis of tacrolimus to assess two immunoassays in patients with liver and renal transplants.
Therapeutic drug monitoring 1997;19(6):694-700.
1997: P W Leighton; DAVID LE COUTEUR; C C Pang; SJ McCann; D Chan; L K Law; R Kay; S m Pond; J Woo
The dopamine transporter gene and Parkinson's disease in a Chinese population.
Neurology 1997;49(6):1577-9.
1997: Paul J Taylor; N S Hogan; Stephen V Lynch; AG Johnson; S m Pond
Improved therapeutic drug monitoring of tacrolimus (FK506) by tandem mass spectrometry.
Clinical chemistry 1997;43(11):2189-90.
1997: DAVID LE COUTEUR; P W Leighton; SJ McCann; S m Pond
Association of a polymorphism in the dopamine-transporter gene with Parkinson's disease.
Movement disorders : official journal of the Movement Disorder Society 1997;12(5):760-3.
1997: Helen M Dodds; Paul J Taylor; L P Johnson; Robin Mortimer; S m Pond; Graeme R Cannell
Cortisol metabolism and its inhibition by glycyrrhetinic acid in the isolated perfused human placental lobule.
The Journal of steroid biochemistry and molecular biology 1997;62(4):337-43.
1997: MR Bowles; T D Mulhern; Ross B Gordon; H R Inglis; Iain A Sharpe; J L Cogill; S m Pond
Bound Tris confounds the identification of binding site residues in a paraquat single chain antibody.
Journal of biochemistry 1997;122(1):101-8.
1997: Helen M Dodds; Paul J Taylor; Graeme R Cannell; S m Pond
A high-performance liquid chromatography-electrospray-tandem mass spectrometry analysis of cortisol and metabolites in placental perfusate.
Analytical biochemistry 1997;247(2):342-7.
1997: Kathryn M Avent; Richard R Riker; gillles fraser; Cornelis J Van Der Schyf; E Usuki; S m Pond
Metabolism of haloperidol to pyridinium species in patients receiving high doses intravenously: is HPTP an intermediate?
Life sciences 1997;61(24):2383-90.
1997: Lodewyk J Mienie; Jacobus J Bergh; E Van Staden; Salome Steyn; S m Pond; Neal Castagnoli; Cornelis J Van Der Schyf
Metabolic defects caused by treatment with the tetrahydropyridine analog of haloperidol (HPTP), in baboons.
Life sciences 1997;61(3):265-72.
1997: Darryl W Eyles; Kathryn M Avent; Terry Stedman; S m Pond
Two pyridinium metabolites of haloperidol are present in the brain of patients at post-mortem.
Life sciences 1997;60(8):529-34.
1997: MR Bowles; DR Hall; S m Pond; Donald J Winzor
Studies of protein interactions by biosensor technology: an alternative approach to the analysis of sensorgrams deviating from pseudo-first-order kinetic behavior.
Analytical biochemistry 1997;244(1):133-43.
1996: Cornelis J Van Der Schyf; Irene C Dormehl; Douglas W Oliver; N Hugo; R Keeve; H W Müller-Gärtner; S m Pond; Neal Castagnoli
Long-term treatment with the tetrahydropyridine analog (HPTP) of haloperidol influences dopamine ligand binding in baboon brain. An [123I]iodobenzamide (IBZM) SPECT study.
Brain research. Molecular brain research 1996;43(1-2):251-8.
1996: Laurent P Rivory; M R Bowles; Jacques Robert; S m Pond
Conversion of irinotecan (CPT-11) to its active metabolite, 7-ethyl-10-hydroxycamptothecin (SN-38), by human liver carboxylesterase.
Biochemical pharmacology 1996;52(7):1103-11.
1996: Helen M Dodds; E T Walpole; Laurent P Rivory; Russell W Strong; S m Pond
Disposition of epirubicin after intraarterial administration in Lipiodol to patients with hepatocellular carcinoma.
Therapeutic drug monitoring 1996;18(5):537-43.
1996: Darryl W Eyles; J J McGrath; S m Pond
Formation of pyridinium species of haloperidol in human liver and brain.
Psychopharmacology 1996;125(3):214-9.
1996: S m Pond; R A Gordon; A L Simi; D J Winzor
Further observations on the measurement of fatty acid incorporation by erythrocyte ghosts to quantify unbound palmitate concentration in albumin-palmitate mixtures.
Analytical biochemistry 1996;237(2):232-8.
1996: Paul J Taylor; A Jones; Glenda A Balderson; Stephen V Lynch; R L Norris; S m Pond
Sensitive, specific quantitative analysis of tacrolimus (FK506) in blood by liquid chromatography-electrospray tandem mass spectrometry.
Clinical chemistry 1996;42(2):279-85.
1996: K M Avent; E Usuki; Darryl W Eyles; R Keeve; Cornelis J Van Der Schyf; Neal Castagnoli; S m Pond
Haloperidol and its tetrahydropyridine derivative (HPTP) are metabolized to potentially neurotoxic pyridinium species in the baboon.
Life sciences 1996;59(17):1473-82.
1996: Laurent P Rivory; K M Avent; S m Pond
Effects of lipophilicity and protein binding on the hepatocellular uptake and hepatic disposition of two anthracyclines, doxorubicin and iododoxorubicin.
Cancer chemotherapy and pharmacology 1996;38(5):439-45.
1996: L Brand; Douglas W Oliver; Cornelis J Van Der Schyf; S m Pond; Neal Castagnoli
Dopamine receptor binding of 4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)- 4-oxobutyl]-1,2,3,6-tetrahydropyridine (HPTP), an intermediate metabolite of haloperidol.
Life sciences 1996;59(10):815-20.
1996: S m Pond; R A Gordon; L Bass
Sex differences in initial clearance of palmitate by human hepatocytes.
European journal of clinical investigation 1996;26(1):76-81.
1995: S m Pond; D J Lewis-Driver; G M Williams; A C Green; N W Stevenson
Gastric emptying in acute overdose: a prospective randomised controlled trial.
The Medical journal of Australia 1995;163(7):345-9.
1995: C M Devlin; M R Bowles; Ross B Gordon; S m Pond
Production of a paraquat-specific murine single chain Fv fragment.
Journal of biochemistry 1995;118(3):480-7.
1995: Helen M Dodds; R L Norris; AG Johnson; S m Pond
Evaluation and comparison of the TDxII, Stratus, and OPUS digoxin assays.
Therapeutic drug monitoring 1995;17(1):68-74.
1994: R L Norris; Peter J Ravenscroft; S m Pond
Sensitive high-performance liquid chromatographic assay with ultraviolet detection of methadone enantiomers in plasma.
Journal of chromatography. B, Biomedical applications 1994;661(2):346-50.
1994: Darryl W Eyles; H R McLennan; A Jones; J J McGrath; Terry Stedman; S m Pond
Quantitative analysis of two pyridinium metabolites of haloperidol in patients with schizophrenia.
Clinical pharmacology and therapeutics 1994;56(5):512-20.
1994: S m Pond; R A Gordon; Z Y Wu; Richard A Weisiger; L Bass
Effects of gender and pregnancy on hepatocellular uptake of palmitic acid: facilitation by albumin.
The American journal of physiology 1994;267(4 Pt 1):G656-62.
1994: Darryl W Eyles; Terry Stedman; S m Pond
Nonlinear relationship between circulating concentrations of reduced haloperidol and haloperidol: evaluation of possible mechanisms.
Psychopharmacology 1994;116(2):161-6.
1994: Paul J Taylor; Paul Salm; R L Norris; Peter J Ravenscroft; S m Pond
Comparison of high-performance liquid chromatography and monoclonal fluorescence polarization immunoassay for the determination of whole-blood cyclosporin A in liver and heart transplant patients.
Therapeutic drug monitoring 1994;16(5):526-30.
1994: DAVID LE COUTEUR; Laurent P Rivory; S m Pond
The effects of aging and nutritional state on hypoxia-reoxygenation injury in the perfused rat liver.
Transplantation 1994;58(5):531-6.
1994: N Chen; M R Bowles; S m Pond
Prevention of paraquat toxicity in suspensions of alveolar type II cells by paraquat-specific antibodies.
Human & experimental toxicology 1994;13(8):551-7.
1994: DAVID LE COUTEUR; Laurent P Rivory; S m Pond
Glucose transport and hypoxia-reoxygenation injury in the perfused rat liver.
Journal of gastroenterology and hepatology 1994;9(4):385-90.
1993: Frank J Burczynski; S m Pond; C K Davis; L P Johnson; Richard A Weisiger
Calibration of albumin-fatty acid binding constants measured by heptane-water partition.
The American journal of physiology 1993;265(3 Pt 1):G555-63.
1993: N Chen; M R Bowles; S m Pond
Polyclonal amanitin-specific antibodies: production and cytoprotective properties in vitro.
Biochemical pharmacology 1993;46(2):327-9.
1993: DAVID LE COUTEUR; Laurent P Rivory; S m Pond
Hepatic intracellular pH during the prereplicative period following partial hepatectomy.
The American journal of physiology 1993;264(4 Pt 1):G767-73.
1993: S m Pond; Laurent P Rivory; E C Hampson; M S Roberts
Kinetics of toxic doses of paraquat and the effects of hemoperfusion in the dog.
Journal of toxicology. Clinical toxicology 1993;31(2):229-46.
1993: H A Whiteford; M R Jarvis; Terry Stedman; S m Pond; John G Csernansky
Mianserin-induced up-regulation of serotonin receptors on normal human platelets in vivo.
Life sciences 1993;53(4):371-6.
1992: Laurent P Rivory; S m Pond; Donald J Winzor
The influence of pH on the interaction of lipophilic anthracyclines with bovine serum albumin. Quantitative characterization by measurement of fluorescence quenching.
Biochemical pharmacology 1992;44(12):2347-55.
1992: M R Bowles; Darryl W Eyles; E C Hampson; S m Pond
Quantitation of paraquat in biological samples by radioimmunoassay using a monoclonal antibody.
Fundamental and applied toxicology : official journal of the Society of Toxicology 1992;19(3):375-9.
1992: H A Whiteford; Terry Stedman; Joy Welham; John G Csernansky; S m Pond
Placebo-controlled, double-blind study of the effects of proglumide in the treatment of schizophrenia.
Journal of clinical psychopharmacology 1992;12(5):337-40.
1992: N Chen; M R Bowles; S m Pond
Competition between paraquat and putrescine for uptake by suspensions of rat alveolar type II cells.
Biochemical pharmacology 1992;44(6):1029-36.
1992: Darryl W Eyles; S m Pond
Stereospecific reduction of haloperidol in human tissues.
Biochemical pharmacology 1992;44(5):867-71.
1992: S m Pond; C K Davis; M A Bogoyevitch; R A Gordon; Richard A Weisiger; L Bass
Uptake of palmitate by hepatocyte suspensions: facilitation by albumin?
The American journal of physiology 1992;262(5 Pt 1):G883-94.
1992: DAVID LE COUTEUR; Laurent P Rivory; M S Roberts; S m Pond
Aging and the response of the isolated perfused rat liver to vasoactive drugs.
Biochemical pharmacology 1992;43(4):913-5.
1992: Laurent P Rivory; Michael S Roberts; S m Pond
Axial tissue diffusion can account for the disparity between current models of hepatic elimination for lipophilic drugs.
Journal of pharmacokinetics and biopharmaceutics 1992;20(1):19-61.
1992: Darryl W Eyles; H A Whiteford; Terry Stedman; S m Pond
Determination of haloperidol and reduced haloperidol in the plasma and blood of patients on depot haloperidol.
Psychopharmacology 1992;106(2):268-74.
1991: B Subramanyam; S m Pond; Darryl W Eyles; H A Whiteford; H G Fouda; Neal Castagnoli
Identification of potentially neurotoxic pyridinium metabolite in the urine of schizophrenic patients treated with haloperidol.
Biochemical and biophysical research communications 1991;181(2):573-8.
1991: Richard A Weisiger; S m Pond; L Bass
Hepatic uptake of protein-bound ligands: extended sinusoidal perfusion model.
The American journal of physiology 1991;261(5 Pt 1):G872-84.
1991: Donald J Winzor; M R Bowles; Paul R Pentel; D D Schoof; S m Pond
Adaptation of the Müller method to allow quantitative characterization of the affinity and cross-reactivity of antibodies by competitive radioimmunoassay.
Molecular immunology 1991;28(9):995-1001.
1991: S m Pond
Extracorporeal techniques in the treatment of poisoned patients.
The Medical journal of Australia 1991;154(9):617-22.
1991: S m Pond; Paul R Pentel; Daniel E Keyler; Donald J Winzor
Determination of the in vivo antigen-antibody affinity constant from the redistribution of desipramine in rats following administration of a desipramine-specific monoclonal antibody.
Biochemical pharmacology 1991;41(3):473-6.
1991: Terry Stedman; H A Whiteford; Darryl W Eyles; Joy Welham; S m Pond
Effects of nifedipine on psychosis and tardive dyskinesia in schizophrenic patients.
Journal of clinical psychopharmacology 1991;11(1):43-7.
1990: M R Bowles; S m Pond
The importance of electrostatic interactions in the binding of paraquat to its elicited monoclonal antibody.
Molecular immunology 1990;27(9):847-52.
1990: E C Hampson; D J Effeney; S m Pond
Efficacy of single or repeated hemoperfusion in a canine model of paraquat poisoning.
The Journal of pharmacology and experimental therapeutics 1990;254(2):732-40.
1990: S m Pond
Manifestations and management of paraquat poisoning.
The Medical journal of Australia 1990;152(5):256-9.
1989: Richard A Weisiger; S m Pond; L Bass
Albumin enhances unidirectional fluxes of fatty acid across a lipid-water interface: theory and experiments.
The American journal of physiology 1989;257(6 Pt 1):G904-16.
1989: T N Tozer; J Callaway; M Hellgeth; Varocha Mahachai; D J Effeney; S m Pond
Concurrent determination of hepatic bioavailability of salicylamide by three techniques in the dog.
Journal of pharmaceutical sciences 1989;78(6):462-4.
1989: E C Hampson; Darryl W Eyles; S m Pond
Effects of paraquat on canine bronchoalveolar lavage fluid.
Toxicology and applied pharmacology 1989;98(2):206-15.
1989: A J Ketterman; M R Bowles; S m Pond
Purification and characterization of two human liver carboxylesterases.
The International journal of biochemistry 1989;21(12):1303-12.
1988: S C Johnston; M Bowles; Donald J Winzor; S m Pond
Comparison of paraquat-specific murine monoclonal antibodies produced by in vitro and in vivo immunization.
Fundamental and applied toxicology : official journal of the Society of Toxicology 1988;11(2):261-7.
1988: P J Robinson; L Bass; S m Pond; Michael S Roberts; J G Wagner
Clinical applicability of current pharmacokinetic models: splanchnic elimination of 5-fluorouracil in cancer patients.
Journal of pharmacokinetics and biopharmaceutics 1988;16(3):229-49.
1988: D J Effeney; E C Hampson; S m Pond
Creation of a carotid-jugular fistula for repeated hemoaccess in a canine model.
Journal of pharmacological methods 1988;19(3):205-11.
1988: S m Pond; Varocha Mahachai; D J Effeney; T N Tozer
Non-linear hepatic first-pass metabolism of salicylamide in dogs after portacaval transposition.
Journal of pharmacokinetics and biopharmaceutics 1988;16(2):161-4.
1988: J A Waschek; R M Fielding; T N Tozer; D J Effeney; S m Pond
Time-dependent, plasma-sulfate-independent kinetics of salicylamide in dogs.
Journal of pharmacokinetics and biopharmaceutics 1988;16(2):151-9.
1988: S m Pond; J A Waschek; V Mahacha; R M Fielding; D J Effeney; T N Tozer
Nonlinear intestinal first-pass metabolism of salicylamide in dogs after portacaval transposition.
The Journal of pharmacology and experimental therapeutics 1988;245(1):291-3.
1988: E C Hampson; S m Pond
Ultrastructure of canine lung during the proliferative phase of paraquat toxicity.
British journal of experimental pathology 1988;69(1):57-68.
1988: E C Hampson; S m Pond
Failure of haemoperfusion and haemodialysis to prevent death in paraquat poisoning. A retrospective review of 42 patients.
Medical toxicology and adverse drug experience 1988;3(1):64-71.
1988: M Bowles; S C Johnston; D D Schoof; Paul R Pentel; S m Pond
Large scale production and purification of paraquat and desipramine monoclonal antibodies and their Fab fragments.
International journal of immunopharmacology 1988;10(5):537-45.
1987: G M Rubin; J A Waschek; S m Pond; D J Effeney; T N Tozer
Concurrent intravenous administration of a labeled tracer to determine the oral bioavailability of a drug exhibiting Michaelis-Menten metabolism.
Journal of pharmacokinetics and biopharmaceutics 1987;15(6):615-31.
1987: S m Pond; S C Johnston; D D Schoof; E C Hampson; M Bowles; D M Wright; J J Petrie
Repeated hemoperfusion and continuous arteriovenous hemofiltration in a paraquat poisoned patient.
Journal of toxicology. Clinical toxicology 1987;25(4):305-16.
1986: J A Waschek; R M Fielding; T N Tozer; D J Effeney; S m Pond
Availability of plasma sulfate for conjugation of salicylamide in dogs.
Biochemical pharmacology 1986;35(3):544-6.
1986: R M Fielding; J A Waschek; D J Effeney; A C Pogany; S m Pond; T N Tozer
Extrahepatic extraction of salicylamide in dogs.
The Journal of pharmacology and experimental therapeutics 1986;236(1):97-102.
1985: J A Waschek; R M Fielding; S m Pond; G M Rubin; D J Effeney; T N Tozer
Dose-dependent sulfoconjugation of salicylamide in dogs: effect of sulfate depletion or administration.
The Journal of pharmacology and experimental therapeutics 1985;234(2):431-4.
1984: J A Waschek; G M Rubin; T N Tozer; R M Fielding; W R Couet; D J Effeney; S m Pond
Dose-dependent bioavailability and metabolism of salicylamide in dogs.
The Journal of pharmacology and experimental therapeutics 1984;230(1):89-93.